Dulaglutide

FDA Drug Profile — Trulicity, TRULICITY

Dulaglutide is listed in the FDA National Drug Code directory with 24 NDC codes, marketed under brand names including Trulicity, TRULICITY. Available dosage forms: injection, solution, solution, powder.

Drug details

Generic Name
Dulaglutide
Brand Names
Trulicity, TRULICITY
Application Number
BLA125469
Sponsor
Eli Lilly And Company
NDC Codes
24
Dosage Forms
INJECTION, SOLUTION, SOLUTION, POWDER
Routes
SUBCUTANEOUS
Active Ingredients
DULAGLUTIDE

Indications and Usage

1 INDICATIONS AND USAGE TRULICITY ® is indicated: As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. To reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus who have established cardiovascular disease or multiple cardiovascular risk factors. TRULICITY ® is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated ( 1 ): As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. To reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus who have established cardiovascular disease or multiple cardiovascular risk factors.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.